Acquisition of chemoresistance in a human ovarian carcinoma cell line is linked to a defect in cell cycle control

International Journal of Cancer

Volumn 78, Issue 4, 1998, Pages 454-463

  Poulain, Laurent ^a   Lincet, Hubert ^a   Duigou, Françoise ^a   Deslandes, Edwige ^a   Sichel, François ^a   Gauduchon, Pascal ^a   Staedel, Cathy ^a  

^a CENTRE FRANÇOIS BACLESSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL CYCLE; CLINICAL PROTOCOL; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL;

EID: 0031725607     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981109)78:4<454::AID-IJC11>3.0.CO;2-6     Document Type: Article

References (21)

1. DARZYNKIEWICZ, Z., BRUNO, S., DEL BINO, G., GORCZYCA, W., HOTZ, M.A., LASSOTA, P. and TRAGANOS, F., Features of apoptotic cells measured by flow cytometry. Cytometry, 13, 795-808 (1992).
2. EASTMAN, A., Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells, 2, 275-280 (1990).
3. ELBENDARY, A., BERCHUCK, A., DAVIS, P., HAVRILESKY, L., BAST, R.C., IGLEHART, D. and MARKS, J.R., Transforming growth factor betal can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ., 5, 1301-1307 (1994).
4. FAJAC, A., DA SILVA, J., AHOMADEGBE, J.C., RATEAU, J.G., BERNAUDIN, J.F., RIOU, G. and BENARD, J., Cisplatin-induced apoptosis and p53 gene status in cisplatin-resistant human ovarian carcinoma cell line. Int. J. Cancer, 68, 67-74 (1996).
5. GAVRIELI, Y., SHERMAN, Y. and BEN-SASSON, S., Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol, 119, 493-501 (1992).
6. HAMILTON, T.C., JOHNSON, S.W. and GODWIN, A.K., Drug resistance in ovarian cancer and potential for its reversal. In: F. Sharp, P. Mason, T. Blackett and J. Bereck (eds.), Ovarian cancer 3, Chapman & Hall, London (1995).
7. JOHNSON, S.W., LAUB, P.B., BEESLEY, J.S., OZOLS, R.F. and HAMILTON, T.C., Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross resistance to various chemotherapeutic agents inunrelated human ovarian cancer cell lines. Cancer Res., 57, 850-856 (1997).
8. JOST, C.A., MARIN, M.C. and KAELIN, W.G., JR., p73 is a human p53-related protein that can induce apoptosis. Nature (Lond.), 389, 191-194 (1997).
9. KERR, J.F.R., WINTERFORD, C.M. and HARMAN, B.V., Apoptosis: its significance in cancer and cancer therapy. Cancer, 73, 2013-2026 (1994).
10. LOWE, S.W., RULEY, H.E., JACKS, T. and HOUSMAN, D.E., p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74, 957-967 (1993).
11. MATSUMOTO, Y., TAKANO, H. and FOJO, T., Cellular adaptation to drug exposure: evolution of the drug-resistant phenotype. Cancer Res., 57, 5086-5092 (1997).
12. MIDGLEY, C.A. and LANE, D.P., p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding. Oncogene, 15, 1179-1189 (1997).
13. MILNER, B.J., ALLAN, L.A., ECCLES, D.M., KITCHENER, H.C., LEONARD, R.C.F., KELLY, K.F., PARKIN, D.E. and HAITES, N.E., p53 mutation is a common genetic event in ovarian carcinoma. Cancer Res., 53, 2128-2132 (1993).
14. ORMEROD, M.G., O'NEIL, C., ROBERTSON, D., KELLAND, L.R. and HARRAP, K.R., Cis-diaminedichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines. Cancer Chemother. Pharmcol., 37, 463-471 (1996).
15. REED, E., Platinum analogs. In: V. de Vita, S. Hellman and S.A. Rosenberg (eds.), Cancer: principle and practice of oncology, Vol. 1 (4th ed.), pp. 390-397 J.B. Lippincott, Philadelphia (1993).
16. SCUDIERO, D.A., SHOEMAKER. R.H., PAULI, K.D., MONSK, A., TIERNEY, S., NOFZIGER, Y.H., CURRENS, M.J., SENIFF, D. and BOYD, M.R., Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res., 48, 4827-4833 (1988).
17. SEGAL-BENDIRDJIAN, E. and JACQUEMIN-SABLON, A., Cisplatin resistance in a murine leukemia cell line is associated with a defective apoptotic process. Exp. Cell Res., 218, 201-212 (1995).
18. WAFI/CIPI induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene, 11, 1899-1905 (1995).
19. SMITH, M.L. and FORNACE. A.J., JR., Mammalian DNA damage-inducible genes associated with growth arrest and apoptosis. Mutation Res., 340, 109-124 (1996).
20. VAISMAN, A., VARCHENKO, M., SAID, I. and CHANEY, S.O., Cell cycle changes associated with formation of Pt-DNA adducts in human ovarian carcinoma cells with different cisplatin sensitivity. Cytometry, 27, 54-64 (1997).
21. WAF/CIPI Nature (Lond.), 381, 713-716 (1996).